Mochida Pharmaceutical Co (TSE:4534) FFO


TSE:4534 Mochida Pharmaceutical Co Ltd TSE:4534
71 GF Score
Price 円3,135.00
GF Value 円3,695.27
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Mochida Pharmaceutical Co FFO?

FFO (Funds from operations) only applies to REITs.

TSE:4534
71GF Score
Mochida Pharmaceutical Co Ltd TSE:4534
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mochida Pharmaceutical Co (TSE:4534) Overvalued in 2026?

Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued. The current stock price of 円3,135.00 is trading 15.2% below its estimated GF Value™ of 円3,695.27. GuruFocus considers Mochida Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4534:

  • FFO:
  • GF Value™: 円3,695.27 vs. price of 円3,135.00 (15.2% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the TSE:4534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mochida Pharmaceutical Co Business Description

Address 1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
71GF Score

Get the complete analysis for TSE:4534

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,135.00
Price
円3,695.27
GF Value